Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Routine Complete Blood Count Components in HELLP Syndrome: A Matched Case Control Study
Abstract
:1. Introduction
2. Material and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Weinstein, L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 1982, 142, 159–167. [Google Scholar] [CrossRef]
- Lam, M.T.C.; Dierking, E. Intensive Care Unit issues in eclampsia and HELLP syndrome. Int. J. Crit. Illn. Inj. Sci. 2017, 7, 136–141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sibai, B.M.; Ramadan, M.K.; Usta, I.; Salama, M.; Mercer, B.M.; Friedman, S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol. 1993, 169, 1000–1006. [Google Scholar] [CrossRef]
- Visser, W.; Wallenburg, H.C. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br. J. Obstet. Gynaecol. 1995, 102, 111–117. [Google Scholar] [CrossRef] [PubMed]
- Benedetto, C.; Marozio, L.; Tancredi, A.; Picardo, E.; Nardolillo, P.; Tavella, A.M.; Salton, L. Biochemistry of HELLP syndrome. Adv. Clin. Chem. 2011, 53, 85–104. [Google Scholar] [PubMed]
- Kinay, T.; Kucuk, C.; Kayikcioglu, F.; Karakaya, J. Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at /=34 Weeks’ Gestation. Balkan Med. J. 2015, 32, 359–363. [Google Scholar] [CrossRef] [PubMed]
- Vigil-de Gracia, P.E.; Tenorio-Maranon, F.R.; Cejudo-Carranza, E.; Helguera-Martinez, A.; Garcia-Caceres, E. Difference between preeclampsia, HELLP syndrome and eclampsia, maternal evaluation. Ginecol. Obstet. Mex. 1996, 64, 377–382. [Google Scholar] [PubMed]
- Cornelius, D.C. Preeclampsia: From Inflammation to Immunoregulation. Clin. Med. Insights Blood Disord. 2018, 11, 1179545X17752325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Canzoneri, B.J.; Lewis, D.F.; Groome, L.; Wang, Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am. J. Perinatol. 2009, 26, 729–732. [Google Scholar] [CrossRef] [PubMed]
- Al Sheeha, M.A.; Alaboudi, R.S.; Alghasham, M.A.; Iqbal, J.; Adam, I. Platelet count and platelet indices in women with preeclampsia. Vasc. Health Risk Manag. 2016, 12, 477–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mannaerts, D.; Heyvaert, S.; de Cordt, C.; Macken, C.; Loos, C.; Jacquemyn, Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J. Matern. Fetal Neonatal. Med. 2019, 32, 1412–1419. [Google Scholar] [CrossRef] [PubMed]
- Serin, S.; Avcı, F.; Ercan, O.; Köstü, B.; Bakacak, M.; Kıran, H. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of pre-eclampsia? Pregnancy Hypertens. 2016, 6, 22–25. [Google Scholar] [CrossRef] [PubMed]
- Cintesun, E.; Incesu Cintesun, F.N.; Ezveci, H.; Akyurek, F.; Celik, C. Systemic inflammatory response markers in preeclampsia. J. Lab. Phys. 2018, 10, 316–319. [Google Scholar] [CrossRef]
- Gogoi, P.; Sinha, P.; Gupta, B.; Firmal, P.; Rajaram, S. Neutrophil-to-lymphocyte ratio and platelet indices in pre-eclampsia. Int. J. Gynaecol. Obstet. 2019, 144, 16–20. [Google Scholar] [CrossRef] [PubMed]
- Yucel, B.; Ustun, B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertens. 2017, 7, 29–32. [Google Scholar] [CrossRef] [PubMed]
- Sibai, B.M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? Am. J. Obstet. Gynecol. 1990, 162, 311–316. [Google Scholar] [CrossRef]
- Katz, L.; de Amorim, M.M.; Figueiroa, J.N.; Pinto e Silva, J.L. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A double-blind, placebo-controlled, randomized clinical trial. Am. J. Obstet. Gynecol. 2008, 198, e281–e288. [Google Scholar] [CrossRef] [PubMed]
- Santos, L.C.; Amorim, M.M.R.; Katz, L.C.; Albuquerque, C.J.M. Terapia Intensiva em Obstetrícia. Rio J. Medsi 2004, 5, 63–75. [Google Scholar]
- Harmon, A.C.; Cornelius, D.C.; Amaral, L.M.; Faulkner, J.L.; Cunningham, M.W., Jr.; Wallace, K.; LaMarca, B. The role of inflammation in the pathology of preeclampsia. Clin. Sci. 2016, 130, 409–419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Romero, R.; Gotsch, F.; Pineles, B.; Kusanovic, J.P. Inflammation in pregnancy: Its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 2007, 65, S194–S202. [Google Scholar] [CrossRef] [PubMed]
HELLP | Controls | p-Value | |
---|---|---|---|
Age (years) | 26.3 [22.3–30.3] | 29.2 [22–34.3] | NS * |
BMI (kg/m2) | 31.1 [25.1–35.1] | 28.5 [27.1–32.1] | NS * |
Parity >1 | 6/14 | 10/14 | NS ** |
Afro-American/Hispanic | 3/14 | 3/14 | NS ** |
GA at delivery (weeks.days) | 35.0 [29.0–37.0] | 39.0 [38.1–40.0] | 0.001 * |
Neonatal birthweight (gr) | 2450 [1030–2665] | 3572 [3333.7–3700] | <0.001 * |
HELLP | Controls | p-Value (Mann-Whitney Test) | |
---|---|---|---|
GA at CBC collection (weeks.days) | 34.0 [28.2–37.1] | 39.0 [38.0–40.0] | <0.001 |
NLR | 5.8 [3.7–16] | 3.6 [2.7–6] | 0.02 |
PLR | 34 [24.4–81.2] | 130.2 [115.5–146.5] | <0.001 |
Hemoglobin (gr/dl) | 11.1 [10.7–12.2] | 11.8 [11.6–12.3] | NS |
Platelet (109/lt) | 71.5 [53.7–79.5] | 223.5 [179–245] | <0.001 |
RDW (%) | 11.1 [10.7–12.2] | 11.8 [11.6–12.3] | NS |
MPV (fL) | 9.1 [7.8–9.7] | 9.4 [7.8–9.9] | NS |
Neutrophil (absolute count) | 10.7 [9–13] | 6.8 [5–8.8] | 0.001 |
Lymphocyte (absolute count) | 1.7 [1–2.5] | 1.6 [1.2–1.8] | NS |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sisti, G.; Faraci, A.; Silva, J.; Upadhyay, R. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Routine Complete Blood Count Components in HELLP Syndrome: A Matched Case Control Study. Medicina 2019, 55, 123. https://doi.org/10.3390/medicina55050123
Sisti G, Faraci A, Silva J, Upadhyay R. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Routine Complete Blood Count Components in HELLP Syndrome: A Matched Case Control Study. Medicina. 2019; 55(5):123. https://doi.org/10.3390/medicina55050123
Chicago/Turabian StyleSisti, Giovanni, Andrea Faraci, Jessica Silva, and Ruchi Upadhyay. 2019. "Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Routine Complete Blood Count Components in HELLP Syndrome: A Matched Case Control Study" Medicina 55, no. 5: 123. https://doi.org/10.3390/medicina55050123